BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20086146)

  • 1. Penicillin sulfone inhibitors of class D beta-lactamases.
    Drawz SM; Bethel CR; Doppalapudi VR; Sheri A; Pagadala SR; Hujer AM; Skalweit MJ; Anderson VE; Chen SG; Buynak JD; Bonomo RA
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1414-24. PubMed ID: 20086146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone.
    Pattanaik P; Bethel CR; Hujer AM; Hujer KM; Distler AM; Taracila M; Anderson VE; Fritsche TR; Jones RN; Pagadala SR; van den Akker F; Buynak JD; Bonomo RA
    J Biol Chem; 2009 Jan; 284(2):945-53. PubMed ID: 18955486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase.
    Bou G; Santillana E; Sheri A; Beceiro A; Sampson JM; Kalp M; Bethel CR; Distler AM; Drawz SM; Pagadala SR; van den Akker F; Bonomo RA; Romero A; Buynak JD
    J Am Chem Soc; 2010 Sep; 132(38):13320-31. PubMed ID: 20822105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of OXA-1 beta-lactamase by penems.
    Bethel CR; Distler AM; Ruszczycky MW; Carey MP; Carey PR; Hujer AM; Taracila M; Helfand MS; Thomson JM; Kalp M; Anderson VE; Leonard DA; Hujer KM; Abe T; Venkatesan AM; Mansour TS; Bonomo RA
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3135-43. PubMed ID: 18559643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
    Philippon LN; Naas T; Bouthors AT; Barakett V; Nordmann P
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the role of Trp105 in the KPC-2 β-lactamase.
    Papp-Wallace KM; Taracila M; Wallace CJ; Hujer KM; Bethel CR; Hornick JM; Bonomo RA
    Protein Sci; 2010 Sep; 19(9):1714-27. PubMed ID: 20662006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone.
    Papp-Wallace KM; Bethel CR; Gootz TD; Shang W; Stroh J; Lau W; McLeod D; Price L; Marfat A; Distler A; Drawz SM; Chen H; Harry E; Nottingham M; Carey PR; Buynak JD; Bonomo RA
    Biochem Pharmacol; 2012 Feb; 83(4):462-71. PubMed ID: 22155308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.
    Papp-Wallace KM; Bethel CR; Distler AM; Kasuboski C; Taracila M; Bonomo RA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):890-7. PubMed ID: 20008772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of KPC-2 β-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226.
    Ke W; Bethel CR; Papp-Wallace KM; Pagadala SR; Nottingham M; Fernandez D; Buynak JD; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2012 May; 56(5):2713-8. PubMed ID: 22330909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural origins of oxacillinase specificity in class D β-lactamases.
    June CM; Vallier BC; Bonomo RA; Leonard DA; Powers RA
    Antimicrob Agents Chemother; 2014; 58(1):333-41. PubMed ID: 24165180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using steric hindrance to design new inhibitors of class C beta-lactamases.
    Trehan I; Morandi F; Blaszczak LC; Shoichet BK
    Chem Biol; 2002 Sep; 9(9):971-80. PubMed ID: 12323371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
    Griggs DJ; Peake L; Johnson MM; Ghori S; Mott A; Piddock LJ
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3357-64. PubMed ID: 19506058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.
    Faheem M; Rehman MT; Danishuddin M; Khan AU
    PLoS One; 2013; 8(2):e56926. PubMed ID: 23437273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
    Papp-Wallace KM; Taracila M; Hornick JM; Hujer AM; Hujer KM; Distler AM; Endimiani A; Bonomo RA
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2867-77. PubMed ID: 20421396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence.
    Totir MA; Cha J; Ishiwata A; Wang B; Sheri A; Anderson VE; Buynak J; Mobashery S; Carey PR
    Biochemistry; 2008 Apr; 47(13):4094-101. PubMed ID: 18324783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.
    Drawz SM; Taracila M; Caselli E; Prati F; Bonomo RA
    Protein Sci; 2011 Jun; 20(6):941-58. PubMed ID: 21404358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.
    Georgopapadakou NH
    Expert Opin Investig Drugs; 2004 Oct; 13(10):1307-18. PubMed ID: 15461559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
    Tajada P; Gomez-Graces JL; Alós JI; Balas D; Cogollos R
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1924-5. PubMed ID: 8843305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the active site carboxy-lysine (K70) of OXA-1 beta-lactamase results in a deacylation-deficient enzyme.
    Schneider KD; Bethel CR; Distler AM; Hujer AM; Bonomo RA; Leonard DA
    Biochemistry; 2009 Jul; 48(26):6136-45. PubMed ID: 19485421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy.
    Nottingham M; Bethel CR; Pagadala SR; Harry E; Pinto A; Lemons ZA; Drawz SM; Akker Fv; Carey PR; Bonomo RA; Buynak JD
    Bioorg Med Chem Lett; 2011 Jan; 21(1):387-93. PubMed ID: 21129961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.